This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Repligen Corp (RGEN)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 8.17M 16.09M 14.16M -1.61M
Operating Gains/Losses 2.11M 93.03K 289.89K -396.47K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 4.96M 1.63M -7.14M 2.86M
(Increase) Decrease in Inventories -860.12K -625.89K 2.73M -870.25K
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 2.29M -733.73K 1.00M 247.22K
(Decrease) Increase In Other Current Liabilities -2.49M 1.26M 2.08M 243.18K
(Increase) Decrease In Other Working Capital -1.04M 1.20M -1.11M 11.49K
Other Non-Cash Items 1.77M 1.06M 1.02M 730.14K
Net Cash From Continuing Operations 18.40M 25.93M 13.44M 2.31M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 18.40M 25.93M 13.44M 2.31M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 34.80M 29.21M 43.21M 71.92M
Purchases of Property, Plant & Equipment -5.60M -4.63M -1.26M -575.46K
Acquisitions -21.24M 0.00 0.00 -26.88M
Purchases of Short-Term Investments -27.51M -42.48M -39.11M -49.47M
Other Cash from Investing Activities -250.00K 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -19.79M -17.91M 2.84M -5.01M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 1.68M 2.45M 1.16M 25.00
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 -330.87K
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 71.96K 0.00 0.00
Net Cash From Financing Activities 1.68M 2.52M 1.16M -330.84K
Effect of Exchange Rate Changes -4.76M 73.97K 602.52K -5.09K
Net Change in Cash & Cash Equivalents -4.47M 10.62M 18.04M -3.04M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for RGEN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 3 3 3
Moderate Buy 0 0 0 0
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

RGEN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs